Rising Cancer Prevalence Fuels Growth Of Antiemetics And Antinauseants Market: Strategic Insights Driving Antiemetics And Antinauseants Market Momentum in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Antiemetics And Antinauseants Market Size By 2025?
The market for antiemetics and antinauseants has been progressively increasing in size over the past few years. It is projected to escalate from $8.19 billion in 2024 to approximately $8.48 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 3.6%. The expansion observed in the previous period can be credited to factors such as traditional branding and market competition, historical preferences in treatment, prevailing economic situations, past global health incidents, and advancements in the medical sector and research.

How Big Is the Antiemetics And Antinauseants Market Size Expected to Grow by 2029?
The market for antiemetics and antinauseants is set to experience constant growth over the next several years, reaching a value of $9.64 billion by 2029 with a compound annual growth rate (CAGR) of 3.3%. This predicted growth can be linked to various factors, including research and development initiatives, economic conditions, market competition, and industry trends, along with shifts in disease patterns and healthcare policies. Foreseen trends for the period include an enhanced focus on patient experience, alterations in healthcare policies, a consumer trend towards non-invasive treatments, an increase in nausea related to chemotherapy and pregnancy, and the advent of targeted therapies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

Which Key Market Drivers Powering Antiemetics And Antinauseants Market Expansion and Growth?
The driving force behind the antiemetics and antinauseants market is the rising prevalence of cancer. Chemotherapy, one of the most advocated treatments for cancer, often results in side effects such as chemotherapy-induced nausea and vomiting (CINV). Antiemetics can mitigate CINV in approximately 60%-70% of patients. For instance, the American Cancer Society, a non-profit organization headquartered in the United States, speculated in April 2024 that nearly 609,000 cancer-related fatalities occurred and around 1.9 million new cancer cases were diagnosed in the country in 2022. It is forecasted that there will be approximately 620,000 cancer-related deaths in 2024, marking a slight increase in mortality rates. The surge in cancer occurrences will enhance the demand for antiemetics and antinauseants, hence contributing to the market revenue.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

What Are the Key Trends Driving Antiemetics And Antinauseants Market Growth?
Leading corporations in the antiemetic and antinauseant market are focusing on the development of new products, such as ready-to-use injectable medications, in order to simplify the treatment procedures and improve patient adherence. These instant-use solutions aim to offer immediate relief, lessening the duration and intricacy related to traditional injectable drugs. For example, in July 2024, Amneal Pharmaceuticals, an American specialty pharmaceutical firm, introduced FOCINVEZ, the pioneer injectable preparation of fosaprepitant made read-to-use, with the intent to curb both immediate and lingering nausea and vomiting triggered by highly emetogenic cancer chemotherapy. This novel product is accessible in a 150 mg/50 mL vial, devoid of Polysorbate 80, and it eliminates the need for reconstitution or dilution, facilitating direct application. For reimbursement purposes, FOCINVEZ is given a distinct J-Code (J1434) and is sanctioned for use in adults and in children as young as six months.

What Are the Emerging Segments in the Antiemetics And Antinauseants Market?
The antiemetics and antinauseants market covered in this report is segmented -

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), s, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types
2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types
3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:
1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone
2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant
3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine
4) By s: Dronabinol, Nabilone
5) By Benzodiazepines: Lorazepam, Diazepam
6) By Anticholinergics: Scopolamine, Glycopyrrolate
7) By Steroids: Dexamethasone, Methylprednisolone
8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron
9) By Other Drug Types: Herbal Remedies, Acupressure Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp

Who Are the Global Leaders in the Antiemetics And Antinauseants Market?
Major companies operating in the antiemetics and antinauseants market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy's Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

Which are the Top Profitable Regional Markets for the Antiemetics And Antinauseants Industry?
North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2441

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.